Onconic Therapeutics Finds Muscle-Preserving Effects When Combined With Obesity Drug
AI 요약 정보
- Onconic tests OCN-501 with semaglutide in obese mice
- In mice, OCN-501 combo improved muscle mass and cut strength loss
- Weight loss: 15.3% with combo vs 13.1% alone; nonsignificant